Previous Article | Next Article ![]()
The Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine
* To whom correspondence should be addressed. Email:
dbweiner{at}mail.med.upenn.edu.
For human immunodeficiency virus type 1 (HIV-1) vaccine development, a central focus is to develop a vaccine that drives primarily strong and broad CD8+ cytotoxic T lymphocytes (CTLs). ...
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
HIV-1 Vaccine Development: Recent Advances in the CTL Platform "Spotty Business"
![]()
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»